RBS

Provectus Biopharmaceuticals Announces Exclusive Worldwide License Agreement with University of Miami for Photodynamic Antimicrobial Treatment of Different Eye Infections with Rose Bengal Sodium

Retrieved on: 
Wednesday, March 27, 2024
Opacity (optics), Risk, Patient, RBS, University, PDAT, Bascom Palmer Eye Institute, Rose bengal, Eye, Infection, Keratitis, Safety, Paratriathlon, Ophthalmology, OBC, Pharmaceutical industry

Provectus would contribute the license to the new entity and have an exclusive RBS supply arrangement with it.

Key Points: 
  • Provectus would contribute the license to the new entity and have an exclusive RBS supply arrangement with it.
  • Rose bengal PDAT emerged under the leadership of Jean-Marie Parel, IngETS-G, Ph.D., FARVO, Director of the Ophthalmic Biophysics Center (“OBC”) at Bascom Palmer Eye Institute (“BPEI”) at the University of Miami Miller School of Medicine.
  • The OBC team and Dr. Parel have spent many years advancing their PDAT technology using rose bengal against different types of treatment-naïve and -resistant keratitis.
  • Dr. Parel said, “Rose bengal PDAT is the result of a lot of hard work by cross-disciplinary contributors at the University of Miami.

NSBC Recognizes the U.S. Coast Guard Office of Boating Safety with the 2024 Silver Schooner Award

Retrieved on: 
Tuesday, April 9, 2024
Organization, Silver, Knowledge, RBS, National Safe Boating Council, Accident, Council, Peg Phillips, Water, Injury, Shipbuilding

CLEARWATER, Fla., April 9, 2024 /PRNewswire-PRWeb/ -- The National Safe Boating Council (NSBC), a national catalyst for recreational boating safety, recognized the U.S. Coast Guard Office of Boating Safety with the 2024 Silver Schooner Award, honoring those with significant contributions to the Council. CG-BSX was honored at the International Boating and Water Safety Summit in Albuquerque, New Mexico on April 8, 2024.

Key Points: 
  • They were honored with a 2024 Silver Schooner Award at the International Boating and Water Safety Summit in Albuquerque, NM on April 8, 2024.
  • CLEARWATER, Fla., April 9, 2024 /PRNewswire-PRWeb/ -- The National Safe Boating Council (NSBC), a national catalyst for recreational boating safety, recognized the U.S. Coast Guard Office of Boating Safety with the 2024 Silver Schooner Award, honoring those with significant contributions to the Council.
  • "At the NSBC, we are thankful for the vision and strategic insight of the U.S. Coast Guard Office of Boating Safety."
  • The U.S. Coast Guard Office of Boating Safety encourages industry stakeholders to support the National Recreational Boating Safety Program (RBS Program).

Alumna's career path became clear when she started the Rutgers business of fashion master's program

Retrieved on: 
Friday, April 5, 2024
New York Fashion Week, Master of Science, Learning, Business, Accounting, RBS, Entrepreneurship, Psychology, Northwestern University, Rutgers University, Project Runway, Multimedia, Basketball, Student, Marketing

NEWARK, N.J., April 5, 2024 /PRNewswire/ -- Her sights set on a career in healthcare, Brooke Pikiell filled her schedule at Northwestern University with pre-med courses. But the pandemic prevented the psychology major from getting hands-on experience in the field. It wasn't until she began an accelerated nursing program after college that she realized it wasn't for her.

Key Points: 
  • Pikiell, who attended Northwestern on a full basketball scholarship, felt she was back at square one on her career quest.
  • While researching options online, she came across Rutgers Business School's Master of Science in Business of Fashion (MSBF).
  • "I'd always been interested in fashion but figured beyond being a designer or model, the career options were few," Pikiell said.
  • The graduate program provides a rigorous academic business school degree tailored to the fashion industry.

Provectus Biopharmaceuticals Announces Notices of Allowance and Award for U.S. Patents of Rose Bengal Sodium in Virology, Pediatric Solid Tumor Cancers, and Vaccines

Retrieved on: 
Tuesday, March 12, 2024
Pharmacology, University, Biochemistry, Patent, Physiology, RBS, Xanthene, Doctor of Philosophy, MD, Infection, Vaccine, Molecular biology, Pharmaceutical industry

KNOXVILLE, TN, March 12, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced that the United States Patent and Trademark Office (“USPTO”) has allowed patent application 17/212,723, titled “Novel Uses of Halogenated Xanthenes in Oncology and Virology.” The application covers the use of Provectus’s pharmaceutical-grade rose bengal sodium (“RBS”) drug substance for the treatment of infectious diseases, such as coronaviruses.

Key Points: 
  • KNOXVILLE, TN, March 12, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced that the United States Patent and Trademark Office (“USPTO”) has allowed patent application 17/212,723, titled “Novel Uses of Halogenated Xanthenes in Oncology and Virology.” The application covers the use of Provectus’s pharmaceutical-grade rose bengal sodium (“RBS”) drug substance for the treatment of infectious diseases, such as coronaviruses.
  • The USPTO has also allowed patent application 17/344,418, titled “In Vitro and Xenograft Anti-Tumor Activity of a Halogenated-Xanthene Against Refractory Pediatric Solid Tumors.” This prospective award covers the use of RBS in combination with one or more immune checkpoint inhibitors and is a continuation of U.S. patent 11,058,664 (2021), Provectus’s first for pediatric oncology.
  • The Company’s previously allowed patent application 17/488,430, titled “Halogenated Xanthenes as Vaccine Adjuvants” (December 2023) and covering RBS’s use as an adjuvant in vaccines to potentially make them work better, will be awarded on March 26, 2024 as U.S. patent 11,938,182.
  • Innovate Calgary, the innovation company of the University of Calgary in Alberta, Canada, is a co-assignee and Aru Narendran, MD, PhD, Professor of Pediatrics, Oncology, Biochemistry and Molecular Biology and Physiology and Pharmacology at the University’s Cumming School of Medicine is a co-inventor on all three patent awards.

Northwind Group Welcomes Robert Kalish as Managing Director, Head of Capital Markets

Retrieved on: 
Wednesday, March 27, 2024
Royal Bank of Scotland, NatWest Markets, Royal Bank, Knowledge, Capital market, RBS, Health care, CRE, KPG

NEW YORK, March 27, 2024 /PRNewswire/ -- Northwind Group, a Manhattan-based real estate private equity firm and debt fund manager, announced today the appointment of Robert Kalish as the company's Managing Director, Head of Capital Markets. In this role, Kalish will lead Northwind's capital markets, fund raising, capital formation and business development initiatives. Kalish will report to Founder and Managing Partner Ran Eliasaf and work closely with the leadership team to oversee company growth. Kalish is well respected in the financial services sector and brings years of experience across multiple alternative investment asset classes and strategies. Over his career, Kalish spearheaded capital formations with about $3B of capital raised across alternative products.

Key Points: 
  • NEW YORK, March 27, 2024 /PRNewswire/ -- Northwind Group , a Manhattan-based real estate private equity firm and debt fund manager, announced today the appointment of Robert Kalish as the company's Managing Director, Head of Capital Markets.
  • In this role, Kalish will lead Northwind's capital markets, fund raising, capital formation and business development initiatives.
  • Kalish will report to Founder and Managing Partner Ran Eliasaf and work closely with the leadership team to oversee company growth.
  • Over his career, Kalish spearheaded capital formations with about $3B of capital raised across alternative products.

Provectus Biopharmaceuticals Announces Acceptance of Pharmaceutical-Grade Rose Bengal Sodium Abstract for Poster Presentation at 2024 Society for Investigative Dermatology (SID) Annual Meeting

Retrieved on: 
Thursday, February 29, 2024
UTHealth School of Dentistry, Division, Toxicity, Wound healing, ID, RBS, Society, Doctor of Philosophy, Safety, University, Control, Assistant professor, Surgery

KNOXVILLE, TN, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced that data from ongoing preclinical research on the topical administration of a formulation of Provectus’s proprietary, pharmaceutical-grade, small molecule, rose bengal sodium (“RBS”) drug substance are being presented at the annual meeting of the Society for Investigative Dermatology (“SID”), to be held May 15-18, 2024 in Dallas, Texas.

Key Points: 
  • KNOXVILLE, TN, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced that data from ongoing preclinical research on the topical administration of a formulation of Provectus’s proprietary, pharmaceutical-grade, small molecule, rose bengal sodium (“RBS”) drug substance are being presented at the annual meeting of the Society for Investigative Dermatology (“SID”), to be held May 15-18, 2024 in Dallas, Texas.
  • The accepted SID abstract is titled “Assessing the safety and toxicity of multi-dosed topical Rose Bengal Sodium (RBS) in a murine model of full-thickness cutaneous injury” (Control ID 4074036, Final ID 813, Current Category: Translational Studies and Early Preclinical to Clinical).
  • The work underlying this poster presentation is part of an ongoing sponsored research program with Amina El Ayadi, Ph.D., Assistant Professor, Division of Surgical Sciences, Department of Surgery at the University of Texas Medical Branch at Galveston to characterize the effects of RBS on full-thickness cutaneous wounds and during the subsequent phases of wound healing.

NOW AVAILABLE: THE GAMECHANGING ORACLE RED BULL RACING RBS#01 ELECTRIC SCOOTER

Retrieved on: 
Tuesday, February 27, 2024
Engineering, Code, Heart, Light, Red Bull Racing, FEA, RBS, Torque, F1, Finite element method, Carbon, Carbon fibers

LONG BEACH, Calif., Feb. 27, 2024 /PRNewswire/ -- After two years of meticulous design and development, the game changing Oracle Red Bull Racing RBS#01 electric scooter is now available and ready to ship — the team's first venture into the consumer product sector.

Key Points: 
  • LONG BEACH, Calif., Feb. 27, 2024 /PRNewswire/ -- After two years of meticulous design and development, the game changing Oracle Red Bull Racing RBS#01 electric scooter is now available and ready to ship — the team's first venture into the consumer product sector.
  • "The RBS#01 marks the launch of Oracle Red Bull Racing's first consumer product," said Rob Gray, Technical Director of Red Bull Advanced Technologies.
  • Designed over the course of 2,500 engineering hours, the RBS#01 is the ultimate electric scooter.
  • To prove the design concept, Oracle Red Bull Racing subjected the scooter to a series of Finite Element Analysis (FEA) tests to ensure it would stand up to extreme use.

Correlate Energy Corp. Appoints Johan Themaat as CFO and Welcomes Two Additional Independent Board Members

Retrieved on: 
Tuesday, January 9, 2024
Lighting, General counsel, Corporation, UC, CFO, First Solar, Knowledge, Nanotechnology, Clean Energy Collective, Correlation, AI, University, Growth, FSLR, University of California, Davis, OTCQB, RBS, Harvard Law School, IPO, Younicos, Innovation system, The arts, Management

BOISE, Idaho, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Correlate Energy Corp. (OTCQB: CIPI) (“Correlate” or the “Company”), a growth-oriented distributed energy company, proudly announces the appointment of Johan Themaat to CFO of Correlate Energy Corp, effective immediately.

Key Points: 
  • BOISE, Idaho, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Correlate Energy Corp. (OTCQB: CIPI) (“Correlate” or the “Company”), a growth-oriented distributed energy company, proudly announces the appointment of Johan Themaat to CFO of Correlate Energy Corp, effective immediately.
  • In conjunction with this appointment, Correlate Energy Corp. is delighted to welcome two distinguished professionals, Dr. Christine Gulbranson and Alina Zagaytova, to its board of directors.
  • Johan Themaat brings a wealth of financial acumen to the role of CFO, having held key positions at prominent companies such as Mission Energy, NGL Energy Partners, and RBS.
  • As Vice President of Finance since September 1, 2023, and previously as CFO of Mission Energy, Themaat has demonstrated his proficiency in guiding companies through strategic financial initiatives.

Provectus Biopharmaceuticals Announces Notice of Allowance of First U.S. Patent of Rose Bengal Sodium for Use as Anticancer and Antiviral Vaccine Adjuvant

Retrieved on: 
Monday, December 18, 2023
Cytokine, AACR, Immunotherapy, Research, The central science, Vaccine, Molecular biology, Patent, MD, Doctor of Philosophy, Pharmacology, Biochemistry, University, Society, T cell, OTCQB, Physiology, Heat shock protein, RBS, Chemokine, SITC

The allowed application would be Provectus’s first patent award in the field of vaccines from the USPTO.

Key Points: 
  • The allowed application would be Provectus’s first patent award in the field of vaccines from the USPTO.
  • Innovate Calgary, the innovation company of the University of Calgary in Alberta, Canada, is a co-assignee.
  • The research underlying the allowed application was led by Dr. Narendran and his lab team (the Narendran Lab).
  • This work also portends the potential benefit of PV-10 in combination with targeted immunotherapies and antibody-drug conjugates for cancer treatment.

Institutional Crypto Brokerage Nonco Secures $10m of aggregate new capital in Seed Round, Led by Valor Capital Group and Hack VC

Retrieved on: 
Monday, December 11, 2023
Professional Services, Blockchain, Technology, Cryptocurrency, Finance, Asset Management, Digital Cash Management, Digital Assets, Theta, RBS, Comptroller, Entrepreneurship, Bastion, Partner, O'Melveny & Myers, BTG, OSL, CMCC, Prime brokerage, Currency, Growth, Knowledge, Merrill (company), Bain Capital Ventures

Nonco, an institutional digital asset brokerage firm, announced the close of its seed round today, in which it received a total of $10m of aggregate new capital.

Key Points: 
  • Nonco, an institutional digital asset brokerage firm, announced the close of its seed round today, in which it received a total of $10m of aggregate new capital.
  • The seed round was a combination of equity and convertible notes, the round was led by Valor Capital Group and Hack VC.
  • The capital will be used by Nonco to continue its growth and serve the Americas growing institutional demand.
  • Fernando Martinez, CEO of Nonco, said: “We want to make a statement, and it begins with our name, Nonco, derived from 'nonconformist.'